DEVELOPMENT AND COMMERCIALIZATION AGREEMENT by and between DURECT CORPORATION and SANDOZ AG dated May 5, 2017Development and Commercialization Agreement • August 9th, 2017 • Durect Corp • Pharmaceutical preparations
This DEVELOPMENT AND COMMERCIALIZATION AGREEMENT (the “Agreement”) is effective as of May 5, 2017 (the “Execution Date”) by and between Sandoz AG, a company organized under the laws of Switzerland, with an office at Lichtstraβe 35, CH 4056, Basel, Switzerland (“SANDOZ”), and Durect Corporation, a Delaware corporation having a place of business at 10260 Bubb Road, Cupertino, California 95014 (“DURECT”). SANDOZ and DURECT are each referred to herein by name or, individually, as a “Party” or, collectively, as the “Parties.”
